Imexpharm Corporation reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported revenue was VND 396,516.72 million compared to VND 487,014.7 million a year ago. Net income was VND 66,595.89 million compared to VND 70,378.37 million a year ago. Basic earnings per share from continuing operations was VND 921 compared to VND 931 a year ago.